SCHEMBL6695217

SCHEMBL6695217

CNCCCC(O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12601461 0.76
SCHEMBL5204225 0.72
SCHEMBL288681 0.72
SCHEMBL2026151 0.71 LMNA (0.38)
SCHEMBL8781415 0.71
SCHEMBL28298892 0.71
SCHEMBL9343010 0.70 LMNA (0.50)
Hydrochloric Acid SCHEMBL380897 0.70
SCHEMBL27610031 0.70
SCHEMBL580257 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114751920-A Antitumor compounds 法马马有限公司 2022-07-15 CN disclosed
EP-4025253-A1 DRUG ANTIBODY CONJUGATES Pharma Mar S.A. (ES) 2022-07-13 EP disclosed
CN-114736219-A Antitumor compounds 法马马有限公司 2022-07-12 CN disclosed
WO-2003092581-A9 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK PHARMACEUTICALS INC (US) 2004-02-19 WO disclosed